10x Genomics Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/S Ratio2.8510.698.0833.9250.99
P/B Ratio2.458.935.1820.3520.62
Price/Tangible Book2.529.195.3621.1321.26
Price/OCF260.86
Enterprise Value Ratios
EV/Revenue2.3310.277.3932.8648.62
Profitability & Returns
Return on Equity (ROE)-0.25%-0.33%-0.20%-0.07%-0.94%
Return on Assets (ROA)-0.13%-0.13%-0.10%-0.03%-0.07%
Return on Capital Employed (ROCE)-0.24%-0.24%-0.18%-0.06%-0.10%
Leverage & Solvency Ratios
Debt/Equity0.120.130.120.100.09
Liquidity Ratios
Current Ratio4.974.694.856.776.55
Quick Ratio4.093.964.086.106.05
Efficiency Ratios
Asset Turnover0.650.620.500.500.39
Inventory Turnover2.502.701.701.652.58
Yield & Distribution Ratios
Earnings Yield-0.11%-0.04%-0.04%0.00%-0.04%
FCF Yield0.00%-0.01%-0.04%-0.01%-0.02%
Buyback Yield-0.03%-0.03%-0.03%-0.09%-1.59%